Comment on fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbidities ecancer 1:26 5 years ago 60 Далее Скачать
Fixed-duration therapy with venetoclax-obinutuzumab in frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 10:24 5 years ago 1 736 Далее Скачать
Six-year update from CLL14: fixed-duration venetoclax + obinutuzumab for previously untreated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 296 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
Fixed-duration ibrutinib and venetoclax for first-line CLL ecancer 7:36 3 years ago 123 Далее Скачать
Fixed-duration treatment strategies for frontline and relapsed CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:56 1 year ago 172 Далее Скачать
CLL14: feasibility of fixed-duration frontline therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 2 years ago 164 Далее Скачать
The future of fixed-duration therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 127 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with previously untreat... ecancer 10:45 5 years ago 103 Далее Скачать
CLL14: Venetoclax plus obinutuzumab for CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:54 3 years ago 983 Далее Скачать
What Is the Best Strategy for Frontline Venetoclax Plus Obinutuzumab in CLL? Blood Cancers Today 0:37 1 year ago 200 Далее Скачать
7-year update on a Phase II trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:44 5 months ago 289 Далее Скачать
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL ecancer 11:23 3 years ago 92 Далее Скачать
Obinutuzumab plus ibrutinib and venetoclax treatment continues to yield high response rates in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:36 3 years ago 97 Далее Скачать
Fixed-duration vs continuous therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:41 2 years ago 362 Далее Скачать
The role of venetoclax in the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:08 3 years ago 544 Далее Скачать
